PharmaTimes | Industry News


	Website and Archive search
	Go

	JobSearch
	Go

Email

Password

Subscribe to the archive

Forgotten password

	MAGAZINE AUDIT BY


	Where am I? > Home > Industry News > UK News

LATEST UK NEWS

Prostrakan, Axis-Shield post double-digit sales growth for 2009
UK-based drugmaker Prostrakan has posted a 41% jump in revenues to £79 million for the year ended December 31, 2009, while Axis-Shield saw its sales climb 13.4% to £96.7 million.

AstraZeneca takes selective approach for emerging markets
AstraZeneca has laid out its plans for growth in the emerging markets which the company notes is not limited to the BRIC (Brazil, Russia, India and China) countries

Vernalis gets $3 million milestone from Novartis
Vernalis has received a cash boost from partner Novartis which is progressing one of the UK’s oncology treatments into mid-stage trials

NICE updates psoriatic arthritis guidance, adding Humira
NICE has this week published draft guidance recommending Wyeth’s Enbrel, Abbott’s Humira and Schering-Plough’s Remicade as treatments for psoriatic arthritis, under certain conditions.

Failures over dementia cannot continue, say MPs
Despite Department of Health assurances that dementia would be a national health priority, it has not been given the same status as cancer and stroke, and the Department does not know how the first £60 million of dementia funding has been spent, say MPs, in a damning new report published today.

GSK's Revolade approved in EU, will take on Amgen's Nplate
GlaxoSmithKline and partner Ligand Pharmaceuticals are celebrating the news that their blood disorder drug Revolade has gained marketing approval in the European Union

More Headlines